$HZNP News Thursday’s biggest gaining and declining

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$HZNP News

Thursday’s biggest gaining and declining stocks 3:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 8:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 8:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 5:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 9:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 11:00 a.m. July 28, 2011 - MarketWatch.com

A Classic Melt-Up 4:25 p.m. Dec. 20, 2013 - RealMoney.com
A Little Follow-Through 10:25 a.m. Dec. 20, 2013 - RealMoney.com
A Very Shallow Pullback 4:20 p.m. Dec. 19, 2013 - RealMoney.com
High Anxiety 1:15 p.m. Dec. 19, 2013 - RealMoney.com
Top Insider Trades: VRX HZNP SEAS LNBB 9:15 a.m. Dec. 18, 2013 - TheStreet.com
Earnings Estimates Moving Higher for Horizon Pharma (HZNP): Time to Buy? - Tale of the Tape 8:40 a.m. Dec. 13, 2013 - Zacks.com
Horizon Pharma (HZNP) In A Perilous Reversal 1:45 p.m. Dec. 2, 2013 - TheStreet.com
The Slow-Motion Rally Rolls On 4:49 p.m. Nov. 22, 2013 - RealMoney.com
Comatose Action 10:47 a.m. Nov. 22, 2013 - RealMoney.com
Horizon Pharma rallies again following Cramer comment 2:31 p.m. Nov. 21, 2013 - Seeking Alpha
Jim Cramer: Buy Fluor, Home Depot, and These 2 Stocks 9:56 a.m. Nov. 21, 2013 - Wall St. Cheat Sheet
Cramer's Lightning Round - Halcon Is Not Bringing Home The Bacon (11/20/13) 7:34 a.m. Nov. 21, 2013 - Seeking Alpha
'Mad Money' Lightning Round: F5 Networks Is a Great Stock 6:00 a.m. Nov. 21, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Forget the Fed's Old News 8:19 p.m. Nov. 20, 2013 - TheStreet.com
Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal 10:00 a.m. Nov. 20, 2013 - TheStreet.com
Horizon: Hold Or Take Profit Now? 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
At a Loss 4:23 p.m. Nov. 19, 2013 - RealMoney.com
Horizon Pharma's CEO Presents at Agreement to Acquire U.S. Rights to Vimovo Conference (Transcript) 3:50 p.m. Nov. 19, 2013 - Seeking Alpha
Horizon Pharma: Speculative Small Cap Moving On News 3:09 p.m. Nov. 19, 2013 - Seeking Alpha
Downright Disgusted 1:39 p.m. Nov. 19, 2013 - RealMoney.com


Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Today - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:29 a.m. Jan. 2, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 19, 2013 - Marketwire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 5, 2013 - Marketwire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 8:00 a.m. Dec. 2, 2013 - PR Newswire
Horizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:30 a.m. Nov. 26, 2013 - Marketwire
Strategic Acquisitions, New Drug Applications, Licensing Agreements, and Financial Results - Research Report on Horizon Pharma, NPS Pharmaceuticals, Spherix, Evoke Pharma, and POZEN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 19, 2013 - ACCESSWIRE
POZEN Announces U.S. Rights for VIMOVO(R) to Be Acquired by Horizon Pharma USA, Inc. 6:15 a.m. Nov. 19, 2013 - BusinessWire
Horizon Pharma Announces Pricing of $150 Million of 5.00% Convertible Senior Notes 6:05 a.m. Nov. 19, 2013 - Marketwire
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance 6:00 a.m. Nov. 19, 2013 - Marketwire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Nov. 12, 2013 - Marketwire
OXBT, HZNP, PPHM and NWBO added to NASDAQ Healthcare Stock Watch List at GSR 10:35 a.m. Nov. 11, 2013 - ACCESSWIRE
Horizon Pharma and Mundipharma Sign Exclusive Agreement to Commercialize LODOTRA(R) in the Middle East and Africa 7:30 a.m. Nov. 11, 2013 - Marketwire
Horizon Pharma Announces Third Quarter 2013 Financial Results, Reports Net Revenue of $26.2 Million 6:30 a.m. Nov. 8, 2013 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 64

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
University of Phoenix Leads Credentialing Dialogue at Summit

Updated Category News Views 42

Credentials in the Spotlight at PESC Summit When you're talking credentials and data standards at the PESC Summit, you've got a gathering of big brains aiming to steer the wild ride of higher education into the future. This October, University of Phoenix leaders stepped up to the plate in Scottsdale, Arizona, delivering a frank talk about the role of credentials in...

Continue Reading
Co-op Giants Earn $309B: Key Players Spotlighted

Updated Category News Views 188

Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...

Continue Reading
ADT Shareholders Face Legal Scrutiny in M&A Deal

Updated Category News Views 19

ADT Shareholders on High Alert Listen up, folks. Anyone holding shares in ADT Inc. (NYSE: ADT) needs to sharpen their pencils and start crunching numbers. This isn't the time to sit back and coast. A M&A Class Action investigation is brewing, and it's centered on ADT's sale to Thrive Holdings. The $10.00 per share buyout offer might look neat and tidy, but there's more to...

Continue Reading
Class Action Looms Over Tenax Therapeutics Investors

Updated Category News Views 51

Shareholders in the Crosshairs Every once in a while, the market serves up a cold dish of reality, and folks owning Tenax Therapeutics (NASDAQ:TENX) are facing just that. A class action is casting a long shadow, targeting those who bought in between November 13, 2023, and August 7, 2026. It's the kind of headache that no investor wakes up hoping for. The Allegations: When...

Continue Reading
PRTH Shareholder Concerns Amid Merger Investigation

Updated Category News Views 79

Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....

Continue Reading
Investigations Target PAG, BRBS, PSNL for Fair Shareholder Deals

Updated Category News Views 64

Unpacking the Shareholder's Dilemma in Major Transactions Alright, folks, let's dig into this mess with our favorite Wall Street magnifying glass. We've got Penske Automotive Group (NYSE: PAG), Blue Ridge Bankshares (NYSE: BRBS), and Personalis, Inc. (NASDAQ: PSNL) under the spotlight, each locking themselves into deals that might not exactly scream 'fair play' for the...

Continue Reading
The Sift: Slickdeals’ Game-Changing Black Friday Tool

Updated Category News Views 272

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Continue Reading
Holiday Shoppers Eye Payment Options Amid Tight Budgets

Updated Category News Views 59

Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....

Continue Reading
Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

Updated Category News Views 80

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments in Titanium Powder Production by PyroGenesis

Updated Category News Views 156

Significant Contract for Titanium Powder Production PyroGenesis Inc., a pioneer in ultra-high temperature processes and a leading technology provider to heavy industry and defense, is making waves in the additive manufacturing sector. The company has announced an initial order for 'fine cut' titanium powder, which has been produced using their advanced NexGen™ plasma...

Continue Reading
Exploring The Impressive Returns of The Hartford Insurance

Updated Category News Views 254

Understanding The Hartford Insurance Group's Growth The Hartford Insurance Group (NYSE: HIG) has displayed impressive market performance over the past five years, outpacing overall market gains significantly. With an annualized return of 26.43%, this company has offered a noteworthy 12.44% lead over the market average. Current market capitalization stands at approximately...

Continue Reading
Exciting New Consumer Product Launches and Trends This Week

Updated Category News Views 520

Highlights of this Week’s Major Consumer Announcements This week brings an exciting selection of consumer and retail news that you won’t want to miss. From the world of fragrances to the latest Halloween trends, here’s a closer look at some captivating announcements that are making waves. Ariana Grande’s Wicked-Inspired Fragrances Ariana Grande has taken things to...

Continue Reading
Occidental Petroleum's Significant Debt Reduction Achievements

Updated Category News Views 274

Occidental Petroleum's Debt Reduction Strategy In a significant stride towards enhancing its financial health, Occidental Petroleum (NYSE: OXY) announced remarkable progress in its debt reduction efforts, achieving a key target of $4.5 billion by the end of 2024. This noteworthy milestone positions the company well as it navigates the complexities of the evolving energy...

Continue Reading
Aptose Unveils Promising New Therapy for AML Patients

Updated Category News Views 218

Aptose Unveils Promising New Therapy for AML Patients In a groundbreaking development, Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) recently announced that the initial patients have been dosed in the TUSCANY Phase 1/2 trial. This innovative trial evaluates the effectiveness of tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA). This trio...

Continue Reading